FC25: Setting Sights Higher With New and Emerging TYK2 Inhibitors for Psoriasis
Released on
October 25, 2025
FC25: Setting Sights Higher With New and Emerging TYK2 Inhibitors for Psoriasis
This activity is supported by educational grants from Takeda Pharmaceuticals U.S.A., Inc.